Bioelectronics Corp (BIEL)

[gimmee greenbacks]

Proof of Concept. Concept met.

“Wearable, noninvasive, pulsed shortwave (radiofrequency) therapy for analgesia and opioid sparing following outpatient surgery: A proof-of-concept case series“

“Six patients avoided opioid use entirely, while the remaining individual required only 5 mg of oxycodone during the first postoperative day.”

MONEY

Conclusions

“These cases demonstrate that the ambulatory use of pulsed shortwave devices is feasible and may be an effective analgesic, possibly obviating opioid requirements following outpatient herniorrhaphy and breast surgery. Considering the lack of any side effects, adverse events, and misuse/dependence/diversion potential, further study with a randomized, controlled trial appears warranted.”

https://onlinelibrary.wiley.com/doi/abs/10.1111/papr.13188